Article PDF
References
Elder MJ, Kilvington S, Dart JK . A clinicopathological study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994;35:1059–64.
Larkin DFP, Easty DL . Experimental Acanthamoeba keratitis. I. Preliminary findings. Br J Ophthalmol 1990;74:551–5.
Neiderkorn JA, Ubelaker JE, McClulley JP, et al. Susceptibility of corneas from various animal species to in vitro binding and invasion by Acanthamoeba castellani. Invest Ophthalmol Vis Sci 1992;33:104–12.
He YG, McCulley JP, Alizadeh H, et al. A pig model of Acanthamoeba keratitis: transmission via contaminated contact lenses. Invest Ophthalmol Vis Sci 1992;33:126–33.
van Klink F, Alizadeh H, He YG, et al. The role of contact lenses, trauma and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1993;34:1937–44.
Wright P, Warhurst D, Jones BR . Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985;69:773–82.
Larkin DFP, Kilvington S, Dart JKG . Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992;99:185–91.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruddell, T., Easty, D. Drug therapy in a murine model of Acanthamoeba keratitis. Eye 9, 142–143 (1995). https://doi.org/10.1038/eye.1995.24
Issue Date:
DOI: https://doi.org/10.1038/eye.1995.24